Parathyroid hormone temporal effects on bone formation and resorption

Bulletin of Mathematical Biology

Volumn 62, Issue 1, 2000, Pages 163-188

  Kroll, Martin H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTERLEUKIN 6; PARATHYROID HORMONE;

AGED; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BONE REMODELING; CALCIUM BONE LEVEL; CELL DIFFERENTIATION; COMPUTER SIMULATION; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; MATHEMATICAL MODEL; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PHYSIOLOGY; RAT; TIME;

ANIMALIA;

EID: 0033972281     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1006/bulm.1999.0146     Document Type: Article

References (42)

1. 2 +and other ions as extracellular (first) messengers. Physiol. Rev. 71:1991;371-411.
2. Burgess T. L. et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145:1999;527-538.
3. Cantor C. R., Schimmel P. R. Biophysical Chemistry, Part III, The Behavior of Biological Macromolecules. 1971;W.H. Freeman & Co. San Francisco. p. 849-866.
4. Dempster D. W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14:1993;690-709.
5. Dobnig H., Turner R. T. Evidence that intermittent treatment with parathryoid hormone increases bone formation in adult rat by activation of bone lining cells. Endocrinology. 136:1995;3632-3638.
6. Finkelstein J. S., Klibanski A., Arnold A. L., Toth T. L., Hornstein M. D., Neer R. M. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone (1-34). J. Am. Med. Assoc. 280:1998;1067-1073.
7. Granner D. K. Hormonal action. Becker K. L. Principles and Practice of Endocrinology and Metabolism. 1995;20-25 J. P. Lippincott Co. Philadelphia.
8. Green J., Schotland S., Sella Z., Kleeman C. R. Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblasts. J. Clin. Invest. 93:1994;2340-2350.
9. Greenfield E. M., Gornik S. A., Horowitz M. C., Donahue H. J., Shaw S. M. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J. Bone Mineral Res. 8:1993;1163-1171.
10. Harms H. M., Kaptaina U., Kulpmann W. R., Brabrant G., Hesch R. D. Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J. Clin. Endocrinol. Metab. 69:1989;843-851.
11. Hesch R. D. Pulsatile secretion of parathyroid hormone and its action on a Type I and Type II PTH receptor: a hypothesis for understanding osteoporosis. Calcif. Tissue. Int. 42:1988;341-344.
12. Hock J. M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Mineral Res. 7:1992;65-72.
13. Horwood N. J., Elliott J., Martin T. J., Gillespie M. T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 139:1998;4743-4746.
14. Hughes F. J., Howells G. L. Interleukin-6 inhibits bone formation in vitro. Bone Miner. 21:1993;21-28.
15. Hurley M. M., Tetradis S., Huang Y.-F., Hock J., Kream B. E., Raisz L. G., Sabbieti M. G. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J. Bone Miner. Res. 14:1999;776-783.
16. Ishizuya T., Yokose S., Hori M., Noda T., Suda T., Yoshiki S., Yamaguchi A. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J. Clin. Invest. 99:1997;2961-2970.
17. Isogai Y. T., Akatsu T., Ishizuya T., Yamaguchi A., Hori M., Tokahashi N., Suda T. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on differentiation stages. J. Bone Mineral Res. 11:1996;1384-1393.
18. Jongen I. W., Willemstein-van Hove E. C., van der Meer J. M., Bos M. P., Juppner H., Segre G. V., Abou-Samra A. B., Feyen J. H., Herrmann-Erlee M. P. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts. J. Bone Miner. Res. 11:1996;1218-1225.
19. Kong Y. Y. et al. OPGL is a key regulator of osteoclastogenensis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323.
20. Mackey M. C., Glass L. Oscillations and chaos in physiological control systems. Science. 197:1977;287-289.
21. Mahoney C. A., Nissenson R. A., Sarnacki P., Pua K. Canine renal receptors for parathyroid hormone. Down-regulation in vivo by exogenous parathyroid hormone. J. Clin. Invest. 72:1983;411-421.
22. McSheehy P. M. J., Chambers T. J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:1986;824-828.
23. Mundy G. R. Cytokines and growth factors in the regulation of bone remodeling. J. Bone Mineral Res. 8, Suppl. 2:1993;S505-S510.
24. Mundy G. R. Cellular and molecular regulation of bone turnover. Bone. 24:1999;35S-38S.
25. Murray J. D. Mathematical Biology. 1989;Springer-Verlag, Berlin. p. 8-12.
26. Oniya J. E., Bidwell J., Herring J., Hulman J., Hock J. M. In vivo, human parathyroid fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone. 17:1995;479-484.
27. Parnas H. Control of neurotransmitter release: use of facilitation to analyze the regulation of intracellular calcium. Segel L. A. Biological Kinetics. 1991;153-181 Cambridge University Press, Cambridge, U.K.
28. Peck W. A. Concensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94:1993;646-650.
29. Perelson A. S. Chaos. Segel L. A. Biological Kinetics. 1991;153-181 Cambridge University Press, Cambridge, U.K.
30. Podbesek R., Edouard C., Meunier P. J., Parsons J. A., Reeve J., Stevenson R. W., Zanelli J. M. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology. 112:1983;1000-1006.
31. Prank K., Harms H., Daemmig M., Brabant G., Mitschke F., Hesch R.-D. Is there low-dimensional chaos in pulsatile secretion of parathyroid hormone in normal human subjects? Am. J. Physiol. 266:1994;E653-E658.
32. Raisz L. G. Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med. 318:1988;818-828.
33. Raisz L. G., Kream B. E. Regulation of bone formation. New Engl. J. Med. 309:1983;29-35.
34. Riggs F. L., Melton III L. J. The prevention and treatment of osteoporosis. N. Engl. J. Med. 327:1992;620-627.
35. Roodman G. D. Osteoclast function in Paget's disease and multiple myeloma. Bone. 17:1995;57S-61S.
36. Rosenberg A. Skeletal system and soft tissue tumors. Cotran R. S., Kumar V., Robbins S. L. Robbins Pathologic Basis of Disease. 1994;1219-1222 W. B. Saunders Co. Philadelphia.
37. Samuels M. H., Veldhuis J., Cawley C., Urban R. J., Luther M., Bauer R., Mundy G. Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. J. Clin. Endocrinol. Metab. 76:1993;399-403.
38. Suda T., Takahashi N., Martin T. J. Modulation of osteoclast differentiation. Endocr. Rev. 13:1992;66-80.
39. Takahashi N., Udagawa N., Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:1999;449-455.
40. Tam C. S., Heersche N. M., Murray T. M., Parsons J. A. Parathyroid hormone stimulates the bone apposition rate independentlly of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 110:1982;506-512.
41. Tohmé J. F., Corman F., Lindsay R. Osteoporosis. Becker K. L. Principles and Practice of Endocrinology and Metabolism. 1995;567-585 J. B. Lippincott Co. Philadelphia.
42. Weryha G., Leclère J. Paracrine regulation of bone remodeling. Horm. Res. 43:1995;69-75.